ArticleJournal of ophthalmology2021

Short-Term Outcomes following "Switching" to Monthly Ranibizumab in Neovascular Age-Related Macular Degeneration Showing Insufficient Response to Bimonthly Aflibercept.

Jong Suk Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.